Chronic alcohol misuse has been reported in 92 % of patients with oral carcinoma and in 61 % of patients with oesophageal carcinoma [1] . Fifty percent of these patients are alcohol-dependent and develop alcohol withdrawal syndrome (AWS) after surgery which can induce potentially life-threatening complications and prolong their stay in the intensive care unit (ICU) [2, 3] . Prevention of AWS by prophylactic drugs is reported to shorten ICU stay in alcohol-dependent patients [2, 3] .
Chronic alcohol misuse has been reported in 92 % of patients with oral carcinoma and in 61 % of patients with oesophageal carcinoma [1] . Fifty percent of these patients are alcohol-dependent and develop alcohol withdrawal syndrome (AWS) after surgery which can induce potentially life-threatening complications and prolong their stay in the intensive care unit (ICU) [2, 3] . Prevention of AWS by prophylactic drugs is reported to shorten ICU stay in alcohol-dependent patients [2, 3] .
There are many different drugs available to treat alcohol withdrawal [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] , but the optimum regimen is not known [20] . Most recommendations are based on studies performed in detoxification units [8] [9] [10] [11] [12] [13] [14] [15] . The transmitter imbalance in these patients is caused by withdrawal of ethanol [21] [22] [23] but after surgery or intubation, stress may aggravate transmitter imbalance, and an increased dose of medication is required in the ICU [4] [5] [6] [7] . Ethanol is not administered in detoxification units, while it is used commonly in the ICU [16] [17] [18] .
In the ICU multiple medications are often preferred as single drug therapy necessitates the use of higher doses compared with detoxification units. The prophylactic regimens used in the present study were chosen from a previous study performed in 672 surgical centres [24] . In 28 %, prophylaxis was not administered because of the difficult preoperative evaluation. As withholding prophylaxis in alcoholdependent patients would lengthen ICU stay [2, 3] , this was deemed unethical; 72 % used ethanol or pharmacological treatment for the prophylaxis of AWS. Pharmacological treatment was based, in the majority of cases, on a combination of benzodiazepine, chlormethiazole, haloperidol and clonidine [4] [5] [6] [7] .
To our knowledge, no controlled studies exist defining which of these standard regimens are most appropriate in the ICU. We have determined if ICU stay, prevention of AWS and major intercurrent complication rate differed between four different standard ICU regimens.
Patients and methods
In this prospective, randomized, clinical study, we studied 197 consecutive patients with carcinoma of the upper digestive tract undergoing tumour resection. All patients gave written informed consent to the study, which was approved by the Ethics Committee of the Benjamin Franklin Medical School, Free University Berlin. Patient age, height, weight, acute physiology and chronic health evaluation score (APACHE II) [25] and multiple organ failure score (MOF) [26] were recorded (table 1) . In addition, patient history and the results of alcoholismrelated questionnaires (CAGE questionnaire [27] and the sMAST [28] ) were obtained before operation (table 1) . The investigator who documented the alcoholism-related history was unaware of the treatment and of the intercurrent complications during ICU stay. All chronic alcoholics fulfilled the DSM-III-R criteria for alcohol dependence [29] . Alcoholdependent patients were allocated randomly to receive one of the following regimens: flunitrazepamclonidine (flu-clon); chlormethiazole-haloperidol (cmz-hp); flunitrazepam-haloperidol (flu-hp); or ethanol.
Patients were excluded if they were less than 18 yr of age, did not undergo surgery, had chronic obstructive lung disease and poor pulmonary function (e.g. chronic hypoxaemia 2 O a P :8 kPa), pneumonia, congestive heart failure, bradycardia :45 beat min
91
, systolic pressure :95 mm Hg, secondor third-degree atrioventricular node block (AVB), pancreatitis, liver insufficiency or had a history of current abuse of benzodiazepines, barbiturates, clonidine or ␤ blockers.
After assignment to a group, a bolus of the test agent was administered immediately after operation on admission to the ICU, followed by a continuous infusion (table 2). The regimen was adapted so that the patients were always arousable while a revised clinical institute withdrawal assessment for alcohol scale (CIWA-Ar) :20 was maintained and controlled hourly in the first 24 h and then four times daily [30] . The CIWA-Ar is a shortened 10-item scale for measurement of the degree of AWS, including vegetative symptoms, hallucinations and symptoms of delirium tremens [30] . The CIWA-Ar was obtained by experienced investigators blinded to the drug regimen. As an adjuvant, all patients were treated with vitamin B1 100 mg day 91 i.v. Serum electrolyte concentrations were measured at least three times daily and abnormalities were treated appropriately. 99 (9) 98 (7) 98 (6) 99 (7) We evaluated 393 patients with carcinoma of the upper digestive tract. After diagnostic procedures, 109 patients did not undergo surgery and therefore were not included in data analysis. Another 64 patients were excluded because of underlying diseases being a contraindication to one of the four regimens: 31 with respiratory disorders, 23 with cardiac disorders, six with gastrointestinal disorders such as pancreatitis and liver insufficiency, and four for other reasons.
Thus we studied 220 patients but 23 were excluded: seven patients in the flu-clon group (one because of the onset of second-degree AVB, two after repetitive bradycardia associated with sustained hypotension, three developed AWS and continued to hallucinate and so required additional therapy with haloperidol (CIWA-Ar 920), and one withdrew consent); six patients in the cmz-hp group (four because of hypersecretion which required tracheal suctioning more than every 5 min, one because of c QT prolongation over 520 ms and one who died before admission to the ICU); five patients in the flu-hp group (two patients because of QTc prolongation (930 % of baseline) which was not caused by hypokalaemia, hypomagnesaemia or bradycardia, one required additional clonidine to treat hypertension, one patient withdrew consent and one was transferred to another hospital); five patients in the ethanol group (two developed hallucinations and delirium tremens which required a change in drug regimen and three who received additional benzodiazepines at night during ICU stay).
Blood was obtained on admission to hospital (table  1) . Serum carbohydrate-deficient transferrin (CDT) was measured by microanion exchange chromatography and subsequent turbidimetry [31] . CDT is a new marker of chronic alcohol misuse [32] which increases after a daily load of 960 g and normalizes within 10-14 days after ethanol withdrawal. A CDT greater than 9 mg litre 91 was defined as pathologically elevated [3] . All other laboratory variables were measured according to standard clinical routines.
The primary outcome measures were duration of ICU stay and prevention of AWS. Secondary outcomes included the overall incidence of major complications. Pneumonia requiring mechanical ventilation, sepsis, cardiac complications, bleeding disorders and death were considered major intercurrent complications. All patients received perioperative antibiotic prophylaxis with cefotiam on admission to the ICU. The antimicrobial regimen was adapted according to the susceptibility of the isolated organisms. If the patient developed pneumonia and no organism was isolated, cefotaxime and gentamicin were administered.
When AWS developed, the diagnosis was made according to an accepted algorithm [33] . Diagnosis was confirmed by a neurologist and symptoms were documented. If the diagnosis of AWS was established and the CIWA-Ar exceeded 20 [30] , a bolus of medication was administered. A CIWA-Ar :20 was required after bolus administration in each group. Patients with persistent CIWA-Ar scores 920 that could not be reversed by increased doses of the drug regimen received additional appropriate medication and were withdrawn from the study.
Infections were determined with respect to CDC criteria [34] . Tracheobronchitis was diagnosed if the patient had at least three of the following five signs or symptoms: cough, rhonchi, wheezing or other auscultatory findings without evidence of pulmonary consolidation, purulent sputum production, body temperature 938 ЊC, leucocystosis or organisms isolated from culture obtained by tracheal aspirate or bronchoscopy. A diagnosis of pneumonia was made if consolidation was evident on a chest x-ray, with the onset of purulent sputum or a change in the character of the sputum, and rales or dullness to percussion on examination were present in the area corresponding to the consolidation. Organisms isolated from specimens obtained by tracheal suctioning or bronchial alveolar lavage are shown in table 4. Sepsis was defined according to the Society of Critical Care Medicine Consensus Conference [35] .
Cardiac complications included bradycardia (:40 beat min
) associated with hypotension, hypotension not reversible with fluid administration, conduction abnormalities, arrhythmias (e.g. three consecutive premature ventricular complexes (PVC), frequent multiform PVC, R-on-T PVC, atrial fibrillation), QTc prolongation 920 % over baseline which was not caused by hypokalaemia, hypomagnesaemia or bradycardia, congestive heart failure with pulmonary or peripheral oedema and angina. Cardiac complications caused by sepsis with sustained hypotension requiring positive inotropes and vasopressors were not included under this category.
A bleeding disorder was diagnosed if the patient required a blood transfusion or surgery because of persistent bleeding. Complications caused by other disease processes such as sepsis requiring fluids and blood transfusion were not included under this category.
All data are expressed as mean (SD) (normally distributed), median (range) (not normally distributed) or frequency. Statistical analysis was performed by the Kruskal-Wallis test for variables not normally distributed or analysis of variance (ANOVA) if variables were normally distributed. If a significant difference was detected by the KruskalWallis test or ANOVA, the Wilcoxon signed rank sum test, the t test for intergroup differences or the chi-square test to compare dichotomous variables were used to determine which groups differed significantly. P : 0.05 was considered significant.
Results
Patient characteristics did not differ significantly between groups (table 1) and there were no significant differences between alcoholism-related history (table 1), laboratory markers (table 1) and severity of the physiological derangement on admission to the ICU (table 3) .
The doses of medication required are given in table 2. The regimens did not differ significantly with respect to the prevention of AWS (table 3) , ICU stay ( fig. 1 ) and the incidence of major intercurrent complications between groups. The incidence of tracheobronchitis was increased significantly in the cmz-hp group (table 3) . Hypersecretion was also more frequent in this group Severe cardiac complications which led to withdrawal from the study were observed with the three regimens: three patients receiving flu-clon, one patient receiving cmz-hp and two patients receiving flu-hp; there was no significant difference between groups (P : 0.3152).
Discussion
In this study the efficacy of each prophylactic regimen was controlled by the CIWA-Ar [30] . One of the problems in the interpretation of clinical trials of various drug regimens for prophylaxis or treatment of AWS is that they do not use validated measures of the dependent variables. The CIWA-Ar relies on a constellation of clinical signs and subjective symptoms and so the presence of other acute illnesses can lead to raised CIWA-Ar values unrelated to alcohol withdrawal. However, the study was performed by experienced investigators who were specifically trained to use the CIWA-Ar in this ICU. Table 3 Scores and complications during ICU stay (mean (SD), median (range) or frequency (%)). Max : maximum; min : minimum; OA ICU : on admission to the ICU; FA ICU : following admission to the ICU; PP : prior to prophylaxis; ND/OR : neck dissection/oesophageal resection; APACHE : acute physiology and chronic health evaluation score; MOF : multiple organ failure score; CIWA-Ar : revised clinical institute withdrawal assessment of alcohol scale; AWS : alcohol withdrawal syndrome; V/H/D : vegetative withdrawal symptoms/hallucinations/delirium tremens; We found that the incidence of AWS did not differ significantly between groups. In most patients AWS was controlled by increased doses. Five patients, three in the flu-clon and two in the ethanol group, were withdrawn because they continued to hallucinate and required haloperidol.
The incidence of AWS in patients receiving
prophylaxis is difficult to state. Drug regimens are complicated in surgical ICU and they differ from other ward settings. This may account for the increased doses required to prevent the symptoms of alcohol withdrawal and the use of combination therapy [24] . As there are, to our knowledge, no controlled studies in surgical ICU, it is difficult to compare the true incidence of AWS in patients receiving prophylaxis with other studies performed in detoxification units.
Benzodiazepines, chlormethiazole, haloperidol and clonidine are commonly used in the treatment of AWS [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] . In contrast, i.v. ethanol as a prophylaxis for AWS is also commonly used but is controversial [16] [17] [18] , probably because most studies of the treatment of AWS are performed in psychiatric wards that aim to detoxify patients. In surgical patients the main goal is to prevent AWS in alcoholdependent patients and to shorten hospital stay [2, 3] . In the ICU, only a single study by Hansbrough and colleagues [16] , the same range as used in the present study. Ethanol administration in this previous study [16] , however, has not been compared with any other standard regimen such as benzodiazepines.
The investigator who performed the CIWA-Ar was unaware of the regimen administered and this reduced any bias that could have occurred in the assessment of prevention and severity of AWS. We did not double-blind the study because no controlled studies in ICU patients and no recommended dosage schedules are available.
ICU stay did not differ between groups. This may result from the low power of the study. But even if two regimens only had been compared, more than 1000 patients would have been required to detect a significant difference, assuming a power of 0.8 and an ␣ of 0.05. Such investigations can only be performed as multicentre studies.
The major side effect of chlormethiazole in our patients was bronchial hypersecretion. Respiratory depression and therefore the necessity for artificial ventilation has been reported with the higher doses required for treatment of AWS [11] . Tracheal intubation, mechanical ventilation and the severity of pre-existing diseases are strongly associated with the risk of developing nosocomial pneumonia, the most common hospital-acquired infection in the ICU [36] [37] [38] . In the present study, the groups did not differ with respect to their pre-existing illnesses and the frequency and duration of mechanical ventilation. The latter may result from vigorous attempts to wean patients from ventilatory support.
There were no differences in major intercurrent complications. However, the study was not designed to have enough power to detect small differences in the rates of these complications. Severe cardiac complications which have been reported for clonidine and haloperidol [5, 39] resulting in withdrawal from the study were distributed equally between the regimens.
